Detalles de la búsqueda
1.
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial.
Lancet
; 402(10416): 1979-1990, 2023 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37898137
2.
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
N Engl J Med
; 382(13): 1208-1218, 2020 03 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32050061
3.
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials.
Am Heart J
; 263: 73-84, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37192697
4.
Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial.
Catheter Cardiovasc Interv
; 101(4): 687-700, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36807456
5.
Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials.
Am Heart J
; 235: 140-148, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33609498
6.
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
Lancet
; 394(10205): 1243-1253, 2019 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31488372
7.
Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction.
Eur Heart J
; 40(24): 1909-1919, 2019 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30851032
8.
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial.
Lancet
; 392(10149): 737-746, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30170848
9.
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study.
Am Heart J
; 209: 97-105, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30703644
10.
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.
Lancet
; 388(10059): 2479-2491, 2016 11 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27806897
11.
Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.
Eur Heart J
; 37(3): 229-40, 2016 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26405232
12.
Biodegradable-polymer stents versus durable-polymer stents - Authors' reply.
Lancet
; 393(10184): 1933, 2019 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31084961
13.
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.
Lancet
; 384(9960): 2111-22, 2014 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-25189359
14.
Biodegradable vs. permanent polymer drug-eluting stents: the need for a new nomenclature to classify drug-eluting stent technology.
Eur Heart J
; 40(31): 2616-2619, 2019 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31132081
15.
Comparison of endothelial shear stress between ultrathin strut bioresorbable polymer drug-eluting stent vs durable-polymer drug-eluting stent post-stent implantation: An optical coherence tomography substudy from BIOFLOW II.
Cardiovasc Revasc Med
; 61: 26-34, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38042738
16.
Patients with higher-atherothrombotic risk vs. lower-atherothrombotic risk undergoing coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials.
Clin Res Cardiol
; 112(9): 1278-1287, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062047
17.
Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT.
Int J Cardiol
; 383: 24-32, 2023 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37080466
18.
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial.
Lancet
; 378(9807): 1940-8, 2011 Dec 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-22075451
19.
Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial.
Eur Heart J
; 32(19): 2454-63, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21659439
20.
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.
Eur Heart J
; 32(3): 294-304, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21123276